Shockwave therapy may aid early return to sport

• by Andrea Surnit

• October 19, 2026

FDA expands treatment in nephrotic syndrome

The indication marks an additional use for a therapy previously approved for certain cancers and active lupus nephritis.

• by Kathryn Wighton

• September 28, 2026

• 2 min

Nirsevimab may curb RSV severity

Real-world estimates showed protection across emergency, inpatient, and intensive care settings during Canada’s first universal immunization season.

• by Andrea Surnit

• September 18, 2026

• 3 min

Marked Increase in Diabetic Ketoacidosis Rates With Modest Increase in HbA1c Elevation at Diabetes Diagnosis in Swedish Children

• by Frida Sundberg, Katarina Eeg-Olofsson, Karin Åkesson

• September 17, 2026